CARLSBAD, Calif., Oct. 20 /PRNewswire/ — Genoptix, Inc.
(Nasdaq:
GXDX), a specialized laboratory services provider, today
announced that it ranked number 41 on Technology Fast 500™,
Deloitte’s ranking of 500 of the fastest growing technology, media,
telecommunications, life sciences and clean technology companies in
North America. Rankings are based on percentage of fiscal year
revenue growth during the five year period from 2005–2009.
Genoptix grew 3,451 percent during this period.
Tina S. Nova, Ph.D., President and CEO of Genoptix, credits
their specialized, physician-directed approach to testing and
diagnosis with the company’s revenue growth. “We are honored
to rank among the top 50 fastest-growing technology companies in
North America for the third year in a row based on our performance
from 2005 to 2009,” said Dr. Nova. “We have grown by focusing
on the needs of community-based hematologists and oncologists and
by adapting to a continually changing environment, and this
recognition is a testament to the exceptional execution of the
entire Genoptix team.”
“Genoptix, Inc. and the other 2010 Technology Fast 500™
winners forged ahead in a challenging economic environment to
realize exceptional growth,” said Phil Asmundson, vice chairman and
Deloitte’s U.S. technology, media and telecommunications leader.
“Deloitte commends Genoptix for this impressive
accomplishment.”
In addition, Genoptix was ranked the second fastest-growing
company in the San Diego region, according to the Technology Fast
500. Overall, Technology Fast 500™ award winners for 2010 had
revenue growth ranging from 146 percent to 164,079 percent from
2005 to 2009, with an average growth of 2,361 percent.
“Genoptix has proved itself to be one of the fastest growing
companies in North America, and we are proud to honor them as one
of the 2010 Technology
‘/>”/>
